Skip to: Content
Skip to: Site Navigation
Skip to: Search

July 25, 2008 9:52:25 PM CDT



New Drug Stirs Debate Over Disease's Existence

Posted Jan 14, 08 4:20 PM CST in Business Science & Health 

(Newser) – The first drug approved by the FDA to treat fibromyalgia is raising questions, but not the typical ones about whether the medication works. They're questions about whether the disease even exists. Lyrica sales are up and climbing, but critics say giving a name to the chronic pain that characterizes fibromyalgia lends the diagnosis undeserved legitimacy, the New York Times reports.

Other companies are preparing similar drugs, and people diagnosed with the condition hail the approval as a step toward bringing an undertreated disease into the mainstream: with the FDA's action, "my pain became real to people," said one patient. Critics, including the doctor who defined the disease, say it's psychological. The doc says his team "thought that we had actually identified a disease, which this clearly is not."

Source New York Times

0 comments | Print E-mail | Digg Seed this on Newsvine Add this link to Del.icio.us StumbleUpon
The world headquarters of Pfizer Inc., the world's largest pharmaceutical company, is shown in this April 12, 2005, file photo in New York. (AP Photo/Mark Lennihan, file)   (Associated Press)
Fibromyalgia is believed to mostly affect middle-aged women who suffer from chronic, widespread pain.   (Shutterstock)
Pfizer is marketing Lyrica, a drug to treat fibromyalgia, but some doctors doubt the disease even exists.   (Shutterstock)
« Prev« Prev | Next »Next » Slideshow
Our editors also recommend:

Threads (1 of 3)

Tags

drugs   FDA   disease   Pfizer   medication



Loading...

Loading...

Today's Most Popular


Other Science & Health Stories

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »